Red Light Therapy for Diabetic Neuropathy: Study Summary

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Photobiomodulation (PBM) shows significant pain reduction in peripheral neuropathies, with 14 studies demonstrating positive effects in chronic pain conditions Systematic Review on PBM for Chronic Pain.
A systematic review covering research from September 2015 to September 2025 identified PBM as a promising therapy for chronic pain, including neuropathies Systematic Review on PBM for Chronic Pain.
The incidence of adverse events with PBM treatments was low, suggesting a strong safety profile for this therapeutic method Systematic Review on PBM for Chronic Pain.
While effective for pain and showing functional gains, the diverse technical parameters used across the 14 studies mean more research is needed to standardize treatment protocols Systematic Review on PBM for Chronic Pain.

Red light therapy, also known as photobiomodulation (PBM), offers a promising non-invasive approach for managing chronic pain, particularly in conditions like diabetic neuropathy. Our analysis of recent systematic reviews shows that PBM can significantly reduce pain in individuals suffering from peripheral neuropathies, including those caused by diabetes. A comprehensive review of 14 studies, published between September 2015 and September 2025, consistently found that PBM led to noticeable pain reduction. These studies also indicated that PBM is a safe treatment option, reporting a low incidence of adverse events. While the evidence supports its efficacy and safety, the varying methods and technical parameters used in these studies highlight a need for more standardized research to optimize treatment protocols for conditions like diabetic neuropathy. This means that while the potential is clear, further work is necessary to pinpoint the best ways to apply this therapy.

What is Photobiomodulation (PBM)?

Photobiomodulation (PBM) is a therapeutic method that uses specific wavelengths of light to trigger beneficial changes within the body's cells. It is considered a non-invasive procedure. This therapy involves directing red and near-infrared lasers or light-emitting diodes (LEDs) onto a specific area of the skin. The goal of PBM is to stimulate cellular activity, particularly within the mitochondria, which are often called the powerhouses of the cells. By modulating mitochondrial function, PBM aims to promote healing, reduce inflammation, and alleviate pain. This mechanism is central to understanding how red light therapy might help with conditions like diabetic neuropathy.

The Science Behind PBM

The light used in PBM is absorbed by chromophores in the cells. These chromophores, primarily cytochrome c oxidase in the mitochondria, react to the light energy. This reaction sets off a cascade of biochemical events. These events can include increased ATP production, enhanced cellular metabolism, and the release of nitric oxide. Increased ATP provides more energy for cellular repair and function. Nitric oxide, on the other hand, can improve local blood flow and reduce oxidative stress. These cellular responses are believed to contribute to the therapeutic effects observed in various conditions. The specific wavelengths of light, typically in the red (around 600-700 nm) and near-infrared (around 780-1100 nm) spectrum, are chosen because they can penetrate skin and tissue effectively to reach the target cells without causing thermal damage. This depth of penetration is crucial for treating deeper tissues and nerves, which is relevant for conditions like peripheral neuropathy.

Distinguishing PBM from Other Light Therapies

It's important to understand that PBM is distinct from other light-based therapies. For example, it differs from high-power laser treatments that are used for surgical purposes or tissue ablation, as PBM uses low-level light that does not generate significant heat or cause tissue damage. It also differs from ultraviolet (UV) light therapy, which is used for skin conditions like psoriasis but carries risks of skin damage and cancer due to its shorter wavelengths. PBM focuses on specific non-ionizing wavelengths that are absorbed by cells to stimulate physiological processes, rather than to destroy or alter tissue structure. The non-invasive nature and lack of significant side effects make PBM an appealing option for chronic conditions. The debate around its efficacy often centers on the variety of protocols and populations studied, which can make it hard to standardize results. However, the fundamental principle remains the same: using light to encourage the body's natural healing capabilities. Understanding these basic principles helps clarify why PBM is being investigated for a range of medical applications, from pain management to vision loss.

Does PBM Help with Neuropathic Pain?

Yes, photobiomodulation (PBM) has shown significant promise in helping with neuropathic pain, including peripheral neuropathies often associated with conditions like diabetes. A comprehensive systematic review, which examined studies published between September 2015 and September 2025, highlighted PBM as a promising therapeutic option for managing chronic pain Systematic Review on PBM for Chronic Pain. This review focused on randomized clinical trials that compared PBM protocols against placebo, sham treatments, or conventional care, providing a robust basis for its findings. The evidence suggests that PBM can offer substantial relief for those suffering from the persistent and often debilitating pain of neuropathy.

Evidence from Systematic Reviews

The systematic review on chronic pain included 14 studies. These studies covered diverse patient populations, including those with fibromyalgia, orofacial pain, musculoskeletal pain, and, importantly, peripheral neuropathies Systematic Review on PBM for Chronic Pain. The primary outcome investigated was pain intensity, with secondary outcomes including functional improvements, quality of life, and the occurrence of adverse events. The findings were largely positive. Most of the trials demonstrated a significant reduction in pain for participants who received PBM treatments. This pain reduction was particularly notable in populations diagnosed with neuropathy and fibromyalgia. Such results suggest that PBM directly impacts the mechanisms contributing to neuropathic pain, potentially by reducing inflammation, promoting nerve regeneration, or modulating pain signals. The consistency of these findings across multiple studies strengthens the argument for PBM's effectiveness in this area.

Mechanisms of Pain Relief in Neuropathy

While the exact mechanisms are still being fully elucidated, several pathways are thought to contribute to PBM's pain-relieving effects in neuropathy. PBM is believed to reduce oxidative stress and inflammation, both of which are key contributors to nerve damage and pain in neuropathic conditions. By enhancing mitochondrial activity, PBM can improve cellular energy production, which is vital for nerve cell repair and function. It may also promote angiogenesis, the formation of new blood vessels, which can improve blood supply to damaged nerves and tissues. Furthermore, PBM can influence nerve conduction velocity and reduce neuronal excitability, thereby directly impacting the perception of pain. The ability of red and near-infrared light to penetrate tissues allows it to reach affected nerve fibers, making it a targeted therapy for localized neuropathic pain. The observed functional gains and improved quality of life in some studies further support that PBM offers more than just symptomatic relief; it can also enhance overall well-being for individuals with chronic neuropathic pain.

Comparing PBM to Conventional Treatments

The systematic review specifically selected randomized clinical trials that compared PBM protocols to placebo, sham, or conventional care Systematic Review on PBM for Chronic Pain. This comparative approach is critical for assessing the true efficacy of a new therapy. While the review noted significant pain reduction, it also highlighted that functional gains and an improved quality of life were observed in some of the studies. This suggests that PBM is not just a pain masker but can contribute to better physical function and an enhanced daily living experience for patients. The fact that it was often compared against conventional care implies that researchers are looking at PBM as a viable alternative or complementary treatment. However, the diverse technical parameters used in the studies, such as light wavelength, intensity, duration, and treatment frequency, make it challenging to establish a single, standardized protocol. This heterogeneity means that while PBM is promising, further research is needed to optimize its application for maximum benefit in neuropathic pain.

Is PBM a Safe Treatment Option?

Yes, photobiomodulation (PBM) appears to be a safe treatment option, especially when considering its application for chronic pain conditions like neuropathy. The systematic review that evaluated PBM for chronic pain specifically reported a low incidence of adverse events Systematic Review on PBM for Chronic Pain. This finding is crucial for any therapeutic intervention, as safety is a primary concern for both patients and healthcare providers. The minimal occurrence of side effects reinforces PBM's profile as a well-tolerated method, making it an attractive alternative or adjunct therapy for long-term conditions.

Low Incidence of Adverse Events

The systematic review included 14 studies that assessed PBM protocols across various chronic pain populations, including those with peripheral neuropathies and fibromyalgia Systematic Review on PBM for Chronic Pain. A key finding from this extensive review was the consistent reporting of a low incidence of adverse events. This means that participants undergoing PBM treatments generally experienced few, if any, negative side effects. The safety profile of PBM is often attributed to its non-invasive nature and the specific wavelengths of light used, which do not cause thermal damage or harmful cellular changes. Unlike some pharmacological treatments for chronic pain, PBM does not carry risks of systemic side effects, addiction, or organ damage. This makes it a considerably safer option for individuals seeking relief from persistent pain. The fact that the review highlighted this low incidence across multiple trials strengthens the confidence in PBM as a safe therapeutic method.

Reinforcing Safety in Practice

The consistent observation of low adverse events across various randomized clinical trials is a strong indicator of PBM's safety. This safety profile is particularly important for chronic conditions where treatments may be ongoing for extended periods. For patients with conditions like diabetic neuropathy, who may already be managing multiple health issues and medications, adding a treatment with minimal side effects can significantly improve their quality of life without introducing new health risks. The non-pharmacological nature of PBM also reduces concerns about drug interactions, which can be a complex issue for individuals on multiple medications. The ability to administer PBM without significant risks makes it more accessible and less burdensome for patients, potentially increasing adherence to treatment protocols. This aspect of safety is paramount when considering long-term management strategies for chronic pain.

Challenges with Standardization

Despite the strong safety profile, the systematic review pointed out a significant challenge: the heterogeneity of technical parameters across the included studies Systematic Review on PBM for Chronic Pain. This refers to the wide variation in light wavelengths, power densities, treatment durations, frequency of sessions, and types of devices used (lasers vs. LEDs). While the method itself is safe, this diversity compromises the standardization of results. It makes it difficult to determine the optimal "dose" or protocol for specific conditions, such as diabetic neuropathy. For instance, one study might use a 660 nm red light with a low power output for 5 minutes, while another might use an 810 nm near-infrared light with higher power for 10 minutes. Both might report positive outcomes, but identifying the most effective parameters becomes complex. This lack of standardization means that while PBM is safe, clinicians and patients might struggle to replicate optimal results consistently. Future research will need to focus on establishing more uniform and evidence-based treatment guidelines to maximize the therapeutic benefits of PBM while maintaining its excellent safety record. This will help move PBM from a promising alternative to a standard therapeutic approach in managing chronic pain.

How Does PBM Compare to Other Treatments?

Photobiomodulation (PBM) is often evaluated in clinical trials by comparing its effects against various control groups, including placebo, sham treatments, or conventional care. This comparative approach helps researchers understand PBM's unique benefits and how it stacks up against established therapies. The systematic review on chronic pain specifically included randomized clinical trials that employed such comparisons Systematic Review on PBM for Chronic Pain. These comparisons are essential for determining PBM's place in the therapeutic landscape for conditions like diabetic neuropathy.

Evidence from Comparative Trials

In the 14 studies analyzed within the systematic review on chronic pain, PBM protocols were directly compared to either placebo, sham interventions, or standard conventional care methods Systematic Review on PBM for Chronic Pain. A placebo group typically receives an inactive treatment, while a sham group undergoes a procedure that mimics the real treatment but without the active component (e.g., a light device that is turned off). These control groups are crucial for isolating the true effects of PBM from psychological factors or the natural course of the condition. The review found that PBM demonstrated significant pain reduction compared to these control groups, particularly in conditions like fibromyalgia and neuropathy. For example, a study on low-level laser therapy (LLLT), a form of PBM, for fibromyalgia showed efficacy in reducing pain Efficacy of Low Power Laser Therapy in Fibromyalgia. Another systematic review and meta-analysis on LLLT for fibromyalgia also supported its effectiveness in pain management Low-Level Laser Therapy for Fibromyalgia Meta-Analysis. This suggests that PBM's benefits are not merely due to a placebo effect but are attributable to the physiological changes induced by the light therapy itself.

Functional Gains and Quality of Life

Beyond just pain reduction, some studies within the systematic review observed that PBM led to functional gains and an improved quality of life for patients Systematic Review on PBM for Chronic Pain. Functional gains refer to improvements in a patient's ability to perform daily activities, move more freely, or experience less physical limitation. For individuals with diabetic neuropathy, this could mean better balance, reduced numbness, or increased comfort during walking. An improved quality of life encompasses a broader sense of well-being, including better sleep, reduced reliance on pain medication, and enhanced mood. These broader benefits are significant because chronic pain often impacts every aspect of a person's life. The ability of PBM to offer these comprehensive improvements positions it as a holistic therapy that addresses both the symptoms and the broader consequences of chronic pain.

PBM as a Complementary or Alternative Therapy

The findings suggest that PBM can serve as a valuable complementary therapy, used alongside conventional treatments, or even as an alternative for patients who cannot tolerate or do not respond well to existing options. For instance, in conditions like diabetic neuropathy, where conventional treatments might include medications with side effects or lifestyle modifications that are hard to maintain, PBM offers a non-pharmacological approach. Its low incidence of adverse events, as highlighted by the systematic review, makes it particularly appealing for long-term use Systematic Review on PBM for Chronic Pain. However, the diverse technical parameters observed across studies—such as varying wavelengths, power outputs, and treatment durations—mean that standardizing PBM protocols is still a work in progress. This heterogeneity complicates direct comparisons with highly standardized conventional treatments. Further research focusing on optimized and consistent PBM protocols would strengthen its position and provide clearer guidance for its integration into clinical practice, ensuring that patients receive the most effective and reliable treatment possible.

What About Whole-Body PBM for Recovery and Performance?

While localized photobiomodulation (PBM) has shown promise for pain relief and healing, particularly in conditions like neuropathy, the efficacy of whole-body PBM for exercise performance and recovery presents a different picture. A systematic review specifically examining whole-body PBM for these purposes found limited evidence of benefit. This distinction is important because the application and expected outcomes can vary significantly depending on whether PBM is applied to a specific area or the entire body.

Findings on Whole-Body PBM

A systematic review conducted by Mario Álvarez-Martínez et al., published in Lasers Med Sci. in 2025, focused on evaluating the efficacy of whole-body PBM for exercise performance and recovery A systematic review on whole-body photobiomodulation for exercise performance and recovery. This review identified a total of five studies out of 193 screened. These five studies included 105 physically active participants of both sexes, engaging in various exercise modalities. The researchers looked for benefits in areas like fatigue biomarkers and overall exercise performance. However, the review concluded that none of the five studies reported any benefit of whole-body PBM on biomarkers of fatigue or exercise performance. This is a crucial finding, suggesting that simply exposing the entire body to red or near-infrared light may not yield the same performance-enhancing or recovery benefits seen with targeted, localized PBM applications.

Impact on Sleep Quality

Despite the lack of evidence for exercise performance and recovery, the whole-body PBM review did note some positive effects in another area: sleep quality. Two of the five studies identified in the review reported better sleep quality among participants using whole-body PBM A systematic review on whole-body photobiomodulation for exercise performance and recovery. This improvement was determined by both subjective questionnaires and commercial sleep trackers. Specific indicators of better sleep included higher serum melatonin levels and a lower nocturnal heart rate. Melatonin is a hormone critical for regulating sleep-wake cycles, and a lower nocturnal heart rate is generally associated with deeper, more restful sleep. These findings suggest that while whole-body PBM might not directly boost athletic performance or speed muscle recovery, it could play a role in improving sleep, which is itself a vital component of overall health and recovery. The potential for PBM to influence circadian rhythms and promote relaxation through systemic effects warrants further investigation.

Discrepancies with Localized PBM

The review explicitly highlighted discrepancies between the findings for whole-body PBM and the established benefits observed in localized PBM studies A systematic review on whole-body photobiomodulation for exercise performance and recovery. Localized PBM, where specific areas like muscles or joints are treated, has been studied extensively as a method to improve exercise performance and recovery. For example, targeted application to a muscle group before or after exercise might reduce muscle soreness, enhance strength, or accelerate tissue repair. The whole-body approach, by contrast, involves irradiating a larger surface area with less concentrated light, potentially diluting the therapeutic effect on specific tissues. The review concluded that further research is necessary to resolve these discrepancies. This means scientists need to understand if the difference is due to dosage, penetration depth, or the specific cellular targets activated by localized versus whole-body exposure. It suggests that while PBM is a promising technology, its application needs to be carefully tailored to the specific therapeutic goal, and "more light" or "more area" does not automatically translate to "more benefit."

Can PBM Help with Other Conditions?

Beyond chronic pain and neuropathies, photobiomodulation (PBM) is being explored for a range of other health conditions, including some that affect vital organs and sensory functions. While the efficacy for some of these conditions remains controversial or requires further research, the underlying principle of modulating cellular activity through light suggests broad therapeutic potential. One notable area of investigation is age-related macular degeneration (AMD), a leading cause of vision loss.

PBM for Age-Related Macular Degeneration (AMD)

Age-related macular degeneration (AMD) is a progressive eye condition that primarily affects central vision. PBM offers a controversial approach for managing dry AMD, which is the more common form of the disease. The goal of using PBM in AMD is to halt or potentially reverse the progression of the condition by modulating mitochondrial activity within the cells of the retina Photobiomodulation efficacy in age-related macular degeneration: a systematic review and meta-analysis of randomized clinical trials. The rationale is that improving mitochondrial function in the retinal pigment epithelium (RPE) cells could enhance their ability to support photoreceptors and clear waste products, which are often impaired in AMD. This could potentially slow down the degeneration process and preserve vision.

Research on PBM and AMD

A systematic review and meta-analysis of randomized clinical trials specifically investigated the efficacy of PBM in patients with dry AMD Photobiomodulation efficacy in age-related macular degeneration: a systematic review and meta-analysis of randomized clinical trials. This review systematically searched major medical databases like PubMed, Embase, and Cochrane for relevant studies. The trials compared PBM against a sham treatment in patients diagnosed with dry AMD. The researchers performed trial sequential analysis (TSA) and minimal clinically important difference (MCID) calculations to assess both statistical and clinical significance of the findings. While PBM aims to halt or reverse AMD progression, the efficacy and clinical relevance of PBM as a potential management approach for dry AMD remain debated. This means that while some studies might show positive trends, the overall scientific consensus on its widespread clinical use for AMD is not yet firmly established. The complexity of AMD and the need for rigorous, long-term studies contribute to this ongoing discussion.

Broader Therapeutic Potential and Future Research

The exploration of PBM for AMD highlights the versatility of this therapy. If PBM can modulate mitochondrial activity in the retina to potentially impact vision, it suggests that similar cellular mechanisms could be targeted in other organs and tissues. Researchers are also investigating PBM for a variety of other conditions beyond pain, such as wound healing, brain injury recovery, and even certain autoimmune disorders. The common thread in these applications is the ability of specific light wavelengths to stimulate cellular repair, reduce inflammation, and improve energy metabolism. However, just as with chronic pain and whole-body PBM for performance, the effectiveness of PBM varies greatly depending on the specific condition, the body part treated, and the precise parameters of the light therapy. The ongoing debate regarding PBM's efficacy for AMD underscores the critical need for more high-quality, standardized randomized controlled trials across all potential applications. Such research will help to clarify which conditions PBM can effectively treat, what the optimal treatment protocols are, and how it compares to existing therapies, ultimately allowing PBM to reach its full therapeutic potential.

Frequently Asked Questions

What is diabetic neuropathy?

Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. High blood sugar (glucose) can injure nerve fibers throughout your body. It most often affects the nerves in the legs and feet, leading to symptoms like pain, tingling, numbness, and weakness. The systematic review on chronic pain included populations with peripheral neuropathies, where PBM demonstrated significant pain reduction across 14 studies Systematic Review on PBM for Chronic Pain.

How does red light therapy work for pain?

Red light therapy, or PBM, works by delivering specific wavelengths of red and near-infrared light to the skin and underlying tissues. This light is absorbed by mitochondria in cells, which then produce more energy (ATP). This process is believed to reduce inflammation, improve blood flow, and stimulate cellular repair and regeneration, ultimately leading to pain reduction. Most trials in a systematic review showed significant pain reduction with PBM, especially in neuropathy and fibromyalgia Systematic Review on PBM for Chronic Pain.

Are there any side effects of PBM for neuropathy?

The systematic review on PBM for chronic pain reported a low incidence of adverse events, reinforcing the method's safety profile Systematic Review on PBM for Chronic Pain. This means that PBM is generally considered safe and well-tolerated, with minimal risks or negative side effects. The non-invasive nature of the treatment contributes to its high safety record compared to pharmacological or surgical interventions.

How often should PBM be applied for neuropathy?

The optimal frequency and duration of PBM application for neuropathy are not yet fully standardized due to the heterogeneity of technical parameters across studies. The systematic review on chronic pain noted that this diversity compromises the standardization of results Systematic Review on PBM for Chronic Pain. Therefore, while PBM shows promise, specific protocols vary, and individual treatment plans would typically be determined by a healthcare provider based on the patient's condition and the specific PBM device used.

Is whole-body PBM effective for conditions other than pain?

A systematic review on whole-body PBM for exercise performance and recovery found no evidence of benefits for these specific outcomes A systematic review on whole-body photobiomodulation for exercise performance and recovery. However, two of the five studies included in that review did report better sleep quality, including higher serum melatonin and lower nocturnal heart rate, with whole-body PBM. This suggests that while it may not enhance athletic performance, it could have other systemic benefits like improving sleep.